Inventor · disambiguated record
Tom Han Hsiao Hsieh
Also filed as: HSIEH TOM · HSIEH TOM HAN HSIAO
20 granted patents·9 pending applications·195 citations·filing 2006–2023
94Inventor score
Files withZYMEWORKS INC7CHAFEEV MIKHAIL5XENON PHARMACEUTICALS INC5ZYMEWORKS BC INC5ADMARE THERAPEUTICS SOC3
Top patents by PatentIndex Score
29 records- 0195US9522876B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Dec 20, 2016·19 cites·48 claims
- 0295US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0395US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0492US9879086B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Jan 30, 2018·11 cites·90 claims
- 0591US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 0691US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 0789US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 0883US10201614B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Feb 12, 2019·3 cites·38 claims
- 0982US12303544B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted May 20, 2025·0 cites·24 claims
- 1082US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 1180US12152083B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted Nov 26, 2024·0 cites·27 claims
- 1280US10414822B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2018·Granted Sep 17, 2019·2 cites·34 claims
- 1379US10450378B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Oct 22, 2019·2 cites·61 claims
- 1477US11279732B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2017·Granted Mar 22, 2022·5 cites·48 claims
- 1574US11560422B2Sulfonamide-containing linkage systems for drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jan 24, 2023·1 cites·38 claims
- 1673US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 1772US11617777B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Apr 4, 2023·0 cites·23 claims
- 1870US2023265173A1Sulfonamide-containing linkage systems for drug conjugatesZYMEWORKS BC INC·Filed 2022·Application pending·0 cites
- 1962US11591405B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Feb 28, 2023·0 cites·18 claims
- 2060US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2160US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2257US12486302B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2021·Granted Dec 2, 2025·0 cites·53 claims
- 2356US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2454US2025326754A1DNA-PK Inhibitor Compounds and Uses ThereofADMARE THERAPEUTICS SOC·Filed 2023·Application pending·0 cites
- 2553US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 2652US10675355B2VAR2CSA-drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jun 9, 2020·0 cites·43 claims
- 2746US2011294842A9Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as painCADIEUX JEAN-JACQUES·Filed 2007·Application pending·0 cites
- 2843US2007105820A1Oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2933US2018312493A1Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses ThereforUNIV FRASER SIMON·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tom Han Hsiao Hsieh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →